Target intelligence / Profile preview

SFT2 domain-containing protein 3 (SFT2D3)

Target: SFT2D3
Molecular classification: Other (putative vesicle transport protein)

Overview

SFT2 domain-containing protein 3 (SFT2D3) is predicted to be involved in protein transport and vesicle-mediated transport, and is localized in several cellular compartments including cytoplasm, endomembrane system, and intracellular membrane-bound organelles. There is no clear evidence that SFT2D3 is a therapeutic target, nor is there established interaction with any current drugs or known direct involvement in specific diseases[2].

Other names: SFT2D3Vesicle transport protein SFT2CMGC5391SFT2 domain containing 3SFT2 domain-containing protein 3vesicle transport protein SFT2C

Biological functions

Protein transportVesicle-mediated transport

Disease associations

Other (no clear, direct disease association documented)

Beyond the preview

Go deeper on SFT2 domain-containing protein 3 (SFT2D3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SFT2 domain-containing protein 3 (SFT2D3).

Explore the full profile